Skip to main content
logo
MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
0.7204
-0.0135 (-1.84%)
At close: Feb 13, 2026, 4:00 PM EST
0.7196
-0.0008 (-0.11%)
After-hours: Feb 13, 2026, 5:56 PM EST

MaxCyte Revenue

MaxCyte had revenue of $6.83M in the quarter ending September 30, 2025, a decrease of -16.35%. This brings the company's revenue in the last twelve months to $34.42M, down -24.52% year-over-year. In the year 2024, MaxCyte had annual revenue of $38.63M, down -6.44%.

Revenue (ttm)
$34.42M
Revenue Growth
-24.52%
P/S Ratio
2.22
Revenue / Employee
$301,921
Employees
114
Market Cap
76.76M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202438.63M-2.66M-6.44%
Dec 31, 202341.29M-2.97M-6.72%
Dec 31, 202244.26M10.37M30.59%
Dec 31, 202133.89M7.73M29.52%
Dec 31, 202026.17M4.55M21.04%
Dec 31, 201921.62M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Accuray436.97M
Xtant Medical Holdings133.08M
Neuronetics129.87M
Outset Medical119.48M
Pulmonx91.66M
Sensus Healthcare27.48M
QT Imaging Holdings11.50M
Hyperfine10.59M
Revenue Rankings

MXCT News

More News